x

Posted 14 September, 2023

YIJIA GROUP CORP. appointed new CEO

CEO Change detected for ticker OTC:YJGJ in a 8-K filed on 14 September, 2023.


  On September 13, 2023, the Board resolved to appoint Ms. Qiuping Lu as the Chief Executive Officer, President, Chief Financial Officer of the Company.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of YIJIA GROUP CORP.
Consumer Goods • Clothing
Yijia Group Corp. engages in providing business consulting services to domestic and international customers. The company was founded on January 25, 2017 and is headquartered in New York, NY.
Market Cap
$3.52M
View Company Details
YIJIA GROUP CORP. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


Mr. Xianchang Ma, previously the Chief Executive Officer, President, Chief Financial Officer and Director of the Company, passed away on August 3, 2023.


On September 13, 2023, the majority shareholder inducted Ms. Qiuping Lu, and Mr. Ruiming Zhou to the Board. On September 13, 2023, the Board resolved to appoint Ms. Qiuping Lu as the Chief Executive Officer, President, Chief Financial Officer of the Company. There are no current or proposed transactions in which Ms. Qiuping Lu or Mr. Ruiming Zhou has an interest that is required to be disclosed under Item 404(a) of Regulation S-K promulgated by the Securities and Exchange Commission ("SEC").


Ms. Lu, aged 51, served as the CEO and CFO of China Herb Group Holdings between 2014 and 2019. Ms. Lu is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Ms. Lu and any other persons pursuant to which she was appointed as Director of the Company.


Mr. Zhou, aged 56, graduated from the First Vocational School of Ba Meng, Inner Mongolia. Since June 2017, he has been serving as a director at Shandong Tengjunxiang Biotechnology Co., Ltd. Mr. Zhou is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Zhou and any other persons pursuant to which she was appointed as Director of the Company.


2